{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:06:59Z","timestamp":1783127219232,"version":"3.54.6"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T00:00:00Z","timestamp":1504569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T00:00:00Z","timestamp":1504569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Abnormality in cellular phosphorylation is closely related to oncogenesis. Thus, kinase inhibitors, especially tyrosine kinase inhibitors (TKIs), have been developed as anti-cancer drugs. Genomic analyses have been used in research on TKI sensitivity, but some types of TKI resistance have been unclassifiable by genomic data. Therefore, global proteomic analysis, especially phosphotyrosine (pY) proteomic analysis, could contribute to predict TKI sensitivity and overcome TKI-resistant cancer. In this study, we conducted deep phosphoproteomic analysis to select active kinase candidates in colorectal cancer intrinsically resistant to Cetuximab. The deep phosphoproteomic data were obtained by performing immobilized metal-ion affinity chromatography-based phosphoproteomic and highly sensitive pY proteomic analyses. Comparison between sensitive (LIM1215 and DLD1) and resistant cell lines (HCT116 and HT29) revealed active kinase candidates in the latter, most of which were identified by pY proteomic analysis. Remarkably, genomic mutations were not assigned in most of these kinases. Phosphorylation-based signaling network analysis of the active kinase candidates indicated that SRC-PRKCD cascade was constitutively activated in HCT116 cells. Treatment with an SRC inhibitor significantly inhibited proliferation of HCT116 cells. In summary, our results based on deep phosphoproteomic data led us to propose novel therapeutic targets against cetuximab resistance and showed the potential for anti-cancer therapy.<\/jats:p>","DOI":"10.1038\/s41598-017-10478-9","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T09:37:09Z","timestamp":1504085829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Deep Phospho- and Phosphotyrosine Proteomics Identified Active Kinases and Phosphorylation Networks in Colorectal Cancer Cell Lines Resistant to Cetuximab"],"prefix":"10.1038","volume":"7","author":[{"given":"Yuichi","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asa","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Isoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tomonaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,5]]},"reference":[{"key":"10478_CR1","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.1075762","volume":"298","author":"G Manning","year":"2002","unstructured":"Manning, G., Whyte, D. B., Martinez, R., Hunter, T. & Sudarsanam, S. The protein kinase complement of the human genome. Science \n                           298, 1912\u20131934, doi:10.1126\/science.1075762 (2002).","journal-title":"Science"},{"key":"10478_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell \n                           144, 646\u2013674, doi:10.1016\/j.cell.2011.02.013 (2011).","journal-title":"Cell"},{"key":"10478_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/35077225","volume":"411","author":"P Blume-Jensen","year":"2001","unstructured":"Blume-Jensen, P. & Hunter, T. Oncogenic kinase signalling. Nature \n                           411, 355\u2013365, doi:10.1038\/35077225 (2001).","journal-title":"Nature"},{"key":"10478_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004652","volume":"6","author":"MJ Niederst","year":"2013","unstructured":"Niederst, M. J. & Engelman, J. A. Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancer. Science signaling \n                           6, re6, doi:10.1126\/scisignal.2004652 (2013).","journal-title":"Science signaling"},{"key":"10478_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature05945","volume":"448","author":"M Soda","year":"2007","unstructured":"Soda, M. et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature \n                           448, 561\u2013566, doi:10.1038\/nature05945 (2007).","journal-title":"Nature"},{"key":"10478_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nrc3612","volume":"13","author":"AT Shaw","year":"2013","unstructured":"Shaw, A. T., Hsu, P. P., Awad, M. M. & Engelman, J. A. Tyrosine kinase gene rearrangements in epithelial malignancies. Nature reviews. Cancer \n                           13, 772\u2013787, doi:10.1038\/nrc3612 (2013).","journal-title":"Nature reviews. Cancer"},{"key":"10478_CR7","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.1141478","volume":"316","author":"JA Engelman","year":"2007","unstructured":"Engelman, J. A. et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science \n                           316, 1039\u20131043, doi:10.1126\/science.1141478 (2007).","journal-title":"Science"},{"key":"10478_CR8","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1038\/onc.2009.234","volume":"28","author":"C Li","year":"2009","unstructured":"Li, C., Iida, M., Dunn, E. F., Ghia, A. J. & Wheeler, D. L. Nuclear EGFR contributes to acquired resistance to cetuximab. Oncogene \n                           28, 3801\u20133813, doi:10.1038\/onc.2009.234 (2009).","journal-title":"Oncogene"},{"key":"10478_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/0003-2697(86)90523-3","volume":"154","author":"L Andersson","year":"1986","unstructured":"Andersson, L. & Porath, J. Isolation of phosphoproteins by immobilized metal (Fe3+) affinity chromatography. Analytical biochemistry \n                           154, 250\u2013254 (1986).","journal-title":"Analytical biochemistry"},{"key":"10478_CR10","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1021\/ac0498617","volume":"76","author":"MW Pinkse","year":"2004","unstructured":"Pinkse, M. W., Uitto, P. M., Hilhorst, M. J., Ooms, B. & Heck, A. J. Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS\/MS and titanium oxide precolumns. Analytical chemistry \n                           76, 3935\u20133943, doi:10.1021\/ac0498617 (2004).","journal-title":"Analytical chemistry"},{"key":"10478_CR11","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1074\/mcp.T600060-MCP200","volume":"6","author":"N Sugiyama","year":"2007","unstructured":"Sugiyama, N. et al. Phosphopeptide enrichment by aliphatic hydroxy acid-modified metal oxide chromatography for nano-LC-MS\/MS in proteomics applications. Molecular & cellular proteomics: MCP \n                           6, 1103\u20131109, doi:10.1074\/mcp.T600060-MCP200 (2007).","journal-title":"Molecular & cellular proteomics: MCP"},{"key":"10478_CR12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1098\/rstb.1998.0228","volume":"353","author":"T Hunter","year":"1998","unstructured":"Hunter, T. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philosophical transactions of the Royal Society of London. Series B, Biological sciences \n                           353, 583\u2013605, doi:10.1098\/rstb.1998.0228 (1998).","journal-title":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences"},{"key":"10478_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1021\/cr990076h","volume":"101","author":"R Aebersold","year":"2001","unstructured":"Aebersold, R. & Goodlett, D. R. Mass spectrometry in proteomics. Chemical reviews \n                           101, 269\u2013295 (2001).","journal-title":"Chemical reviews"},{"key":"10478_CR14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1021\/acs.jproteome.6b00576","volume":"16","author":"Y Abe","year":"2017","unstructured":"Abe, Y., Nagano, M., Tada, A., Adachi, J. & Tomonaga, T. Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS\/MS Parameters. Journal of proteome research \n                           16, 1077\u20131086, doi:10.1021\/acs.jproteome.6b00576 (2017).","journal-title":"Journal of proteome research"},{"key":"10478_CR15","doi-asserted-by":"publisher","first-page":"D512","DOI":"10.1093\/nar\/gku1267","volume":"43","author":"PV Hornbeck","year":"2015","unstructured":"Hornbeck, P. V. et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic acids research \n                           43, D512\u2013520, doi:10.1093\/nar\/gku1267 (2015).","journal-title":"Nucleic acids research"},{"key":"10478_CR16","doi-asserted-by":"publisher","unstructured":"UniProt: a hub for protein information. Nucleic acids research \n                           43, D204\u2013212, doi:10.1093\/nar\/gku989 (2015).","DOI":"10.1093\/nar\/gku989"},{"key":"10478_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2003573","volume":"6","author":"P Casado","year":"2013","unstructured":"Casado, P. et al. Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Science signaling \n                           6, rs6, doi:10.1126\/scisignal.2003573 (2013).","journal-title":"Science signaling"},{"key":"10478_CR18","doi-asserted-by":"publisher","first-page":"D805","DOI":"10.1093\/nar\/gku1075","volume":"43","author":"SA Forbes","year":"2015","unstructured":"Forbes, S. A. et al. COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer. Nucleic acids research \n                           43, D805\u2013811, doi:10.1093\/nar\/gku1075 (2015).","journal-title":"Nucleic acids research"},{"key":"10478_CR19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1999.79.1.143","volume":"79","author":"C Widmann","year":"1999","unstructured":"Widmann, C., Gibson, S., Jarpe, M. B. & Johnson, G. L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiological reviews \n                           79, 143\u2013180 (1999).","journal-title":"Physiological reviews"},{"key":"10478_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0898-6568(99)00071-6","volume":"12","author":"K Ono","year":"2000","unstructured":"Ono, K. & Han, J. The p38 signal transduction pathway: activation and function. Cellular signalling \n                           12, 1\u201313 (2000).","journal-title":"Cellular signalling"},{"key":"10478_CR21","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/bjc.2016.313","volume":"115","author":"L Marzi","year":"2016","unstructured":"Marzi, L. et al. FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer. British journal of cancer \n                           115, 1223\u20131233, doi:10.1038\/bjc.2016.313 (2016).","journal-title":"British journal of cancer"},{"key":"10478_CR22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/onc.2012.90","volume":"32","author":"M Iida","year":"2013","unstructured":"Iida, M., Brand, T. M., Campbell, D. A., Li, C. & Wheeler, D. L. Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor. Oncogene \n                           32, 759\u2013767, doi:10.1038\/onc.2012.90 (2013).","journal-title":"Oncogene"},{"key":"10478_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","volume":"11","author":"W De Roock","year":"2010","unstructured":"De Roock, W. et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. The Lancet. Oncology \n                           11, 753\u2013762, doi:10.1016\/S1470-2045(10)70130-3 (2010).","journal-title":"The Lancet. Oncology"},{"key":"10478_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nature14969","volume":"526","author":"A Bertotti","year":"2015","unstructured":"Bertotti, A. et al. The genomic landscape of response to EGFR blockade in colorectal cancer. Nature \n                           526, 263\u2013267, doi:10.1038\/nature14969 (2015).","journal-title":"Nature"},{"key":"10478_CR25","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M111.015222","volume":"11","author":"MV Myers","year":"2012","unstructured":"Myers, M. V., Manning, H. C., Coffey, R. J. & Liebler, D. C. Protein expression signatures for inhibition of epidermal growth factor receptor-mediated signaling. Molecular & cellular proteomics: MCP \n                           11, M111 015222, doi:10.1074\/mcp.M111.015222 (2012).","journal-title":"Molecular & cellular proteomics: MCP"},{"key":"10478_CR26","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1074\/mcp.M113.033845","volume":"13","author":"M Masuda","year":"2014","unstructured":"Masuda, M. et al. Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profiling. Molecular & cellular proteomics: MCP \n                           13, 1429\u20131438, doi:10.1074\/mcp.M113.033845 (2014).","journal-title":"Molecular & cellular proteomics: MCP"},{"key":"10478_CR27","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic acids research \n                           45, D353\u2013D361, doi:10.1093\/nar\/gkw1092 (2017).","journal-title":"Nucleic acids research"},{"key":"10478_CR28","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.3390\/ijms15045838","volume":"15","author":"N Song","year":"2014","unstructured":"Song, N. et al. Cetuximab-induced MET activation acts as a novel resistance mechanism in colon cancer cells. International journal of molecular sciences \n                           15, 5838\u20135851, doi:10.3390\/ijms15045838 (2014).","journal-title":"International journal of molecular sciences"},{"key":"10478_CR29","doi-asserted-by":"publisher","first-page":"14486","DOI":"10.1074\/jbc.M509332200","volume":"281","author":"EM Khan","year":"2006","unstructured":"Khan, E. M. et al. Epidermal growth factor receptor exposed to oxidative stress undergoes Src- and caveolin-1-dependent perinuclear trafficking. The Journal of biological chemistry \n                           281, 14486\u201314493, doi:10.1074\/jbc.M509332200 (2006).","journal-title":"The Journal of biological chemistry"},{"key":"10478_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-7-69","volume":"7","author":"K Dittmann","year":"2008","unstructured":"Dittmann, K., Mayer, C., Kehlbach, R. & Rodemann, H. P. Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Molecular cancer \n                           7, 69, doi:10.1186\/1476-4598-7-69 (2008).","journal-title":"Molecular cancer"},{"key":"10478_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9033","volume":"6","author":"CD Terfve","year":"2015","unstructured":"Terfve, C. D., Wilkes, E. H., Casado, P., Cutillas, P. R. & Saez-Rodriguez, J. Large-scale models of signal propagation in human cells derived from discovery phosphoproteomic data. Nature communications \n                           6, 8033, doi:10.1038\/ncomms9033 (2015).","journal-title":"Nature communications"},{"key":"10478_CR32","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cell.2016.07.007","volume":"166","author":"JM Drake","year":"2016","unstructured":"Drake, J. M. et al. Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate. Cancer. Cell \n                           166, 1041\u20131054, doi:10.1016\/j.cell.2016.07.007 (2016).","journal-title":"Cancer. Cell"},{"key":"10478_CR33","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.1021\/pr500845u","volume":"13","author":"J Adachi","year":"2014","unstructured":"Adachi, J. et al. Proteome-wide discovery of unknown ATP-binding proteins and kinase inhibitor target proteins using an ATP probe. Journal of proteome research \n                           13, 5461\u20135470, doi:10.1021\/pr500845u (2014).","journal-title":"Journal of proteome research"},{"key":"10478_CR34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1021\/pr700658q","volume":"7","author":"T Masuda","year":"2008","unstructured":"Masuda, T., Tomita, M. & Ishihama, Y. Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis. Journal of proteome research \n                           7, 731\u2013740, doi:10.1021\/pr700658q (2008).","journal-title":"Journal of proteome research"},{"key":"10478_CR35","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1002\/pmic.200900011","volume":"9","author":"M Matsumoto","year":"2009","unstructured":"Matsumoto, M. et al. Large-scale proteomic analysis of tyrosine-phosphorylation induced by T-cell receptor or B-cell receptor activation reveals new signaling pathways. Proteomics \n                           9, 3549\u20133563, doi:10.1002\/pmic.200900011 (2009).","journal-title":"Proteomics"},{"key":"10478_CR36","doi-asserted-by":"publisher","first-page":"7899","DOI":"10.1021\/acs.analchem.6b01232","volume":"88","author":"J Adachi","year":"2016","unstructured":"Adachi, J. et al. Improved Proteome and Phosphoproteome Analysis on a Cation Exchanger by a Combined Acid and Salt Gradient. Analytical chemistry \n                           88, 7899\u20137903, doi:10.1021\/acs.analchem.6b01232 (2016).","journal-title":"Analytical chemistry"},{"key":"10478_CR37","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nature biotechnology \n                           26, 1367\u20131372, doi:10.1038\/nbt.1511 (2008).","journal-title":"Nature biotechnology"},{"key":"10478_CR38","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.celrep.2014.07.036","volume":"8","author":"K Sharma","year":"2014","unstructured":"Sharma, K. et al. Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser\/Thr-based signaling. Cell reports \n                           8, 1583\u20131594, doi:10.1016\/j.celrep.2014.07.036 (2014).","journal-title":"Cell reports"},{"key":"10478_CR39","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nature methods \n                           13, 731\u2013740, doi:10.1038\/nmeth.3901 (2016).","journal-title":"Nature methods"},{"key":"10478_CR40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nmeth.2968","volume":"11","author":"H Horn","year":"2014","unstructured":"Horn, H. et al. KinomeXplorer: an integrated platform for kinome biology studies. Nature methods \n                           11, 603\u2013604, doi:10.1038\/nmeth.2968 (2014).","journal-title":"Nature methods"},{"key":"10478_CR41","doi-asserted-by":"publisher","first-page":"D1107","DOI":"10.1093\/nar\/gkw1080","volume":"45","author":"S Okuda","year":"2017","unstructured":"Okuda, S. et al. jPOSTrepo: an international standard data repository for proteomes. Nucleic acids research \n                           45, D1107\u2013D1111, doi:10.1093\/nar\/gkw1080 (2017).","journal-title":"Nucleic acids research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10478-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10478-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10478-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T10:15:55Z","timestamp":1671790555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10478-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,5]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["10478"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-10478-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,5]]},"assertion":[{"value":"16 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10463"}}